[Effects of the beta-blocking agent atenolol on arrhythmias especially ventricular fibrillation and fibrillation threshold after acute experimental coronary artery occlusion (author's transl)].
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D001262:Atenolol / Q000097:blood / Q000494:pharmacology*; D002339:Carotid Arteries / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D004285:Dogs; D007545:Isoproterenol / Q000494:pharmacology; D008026:Ligation; D010101:Oxygen Consumption / Q000187:drug effects; D011412:Propanolamines / Q000494:pharmacology*; D013610:Tachycardia / Q000517:prevention & control; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000517:prevention & control
D011412:Propanolamines; D001262:Atenolol; D007545:Isoproterenol
Wirkung des beta-Sympathikolytikums Atenolol auf die Arrhythmien, speziell das Kammerflimmern und die Flimmerschwelle des Herzens beim akuten experimentellen Koronarverschluss.